lymphoma treatment
lymphoma treatment
Spanish Company Acquires ALS Treatment for €1225m
BIOT
🇪🇸 Spanish Ferrer Internacional, SA pays €122.5m for ALS candidate, VRG50635, with promising Phase I trial results. 💰🧪
Novartis Boosts Portfolio with Monjuvi Acquisition
BIOT
📰 Novartis acquires MorphoSys, gaining access to Monjuvi for lymphoma treatment. 🤝 Strengthens portfolio, expands biotech presence. 😊 Incyte benefits from collaboration agreement. 💼 Reflects global biotech growth.
